← Back to All Filings

Former Director Files Intent to Sell $514k of SGRY Stock

High SignificanceOctober 14, 2025 at 4:37:57 PM EDT

Surgery Partners, Inc.

$SGRY144CIK: 0001638833

Subscribe to track SGRY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Former Director Files Intent to Sell $514k of SGRY Stock

Company: Surgery Partners, Inc. (SGRY) Form: 144 | Filed: 2025-10-14 Significance: High

Insider: Wayne DeVeydt Title: former director | Relationship: Director

Transaction (Proposed): • Type: Sale • Shares: 25,000 • Approx. Value: $513,568 • Approx. Price: $20.54

Key Insight: This filing is a notice of a proposed sale. It's part of a significant and consistent pattern of selling by the former director, who has sold nearly $17 million worth of stock in the preceding three months.

Market Context: The liquidation by a former director is often planned post-departure and may not signal new negative information. However, the sheer volume of sales is notable and could create selling pressure on the stock.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Surgery Partners, Inc. (SGRY)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: A former director of Surgery Partners, Inc. has filed a Form 144, indicating an intention to sell 25,000 shares valued at approximately $514k. This is part of a larger, consistent pattern of liquidation, with the same insider having sold nearly $17 million in company stock over the prior three months.
  • Market Impact: While sales from former insiders are less alarming than those from current executives, the substantial and sustained volume of selling could place downward pressure on the stock price and may be interpreted as a bearish signal by the market, regardless of the individual's motivation.

Company Information

FieldValue
CompanySurgery Partners, Inc.
Ticker SymbolSGRY (not listed in filing)
CIK0001638833
IndustryGeneral Medical & Surgical Hospitals

Insider Information

FieldValue
NameWayne DeVeydt
CIK0001321392
Title/Positionformer director
RelationshipDirector

Transaction Details

This filing is a Form 144, which is a notice of a proposed sale of securities.

FieldValue
Form Type144
Approx. Sale Date2025-10-14
Transaction CodeS (Implied Sale)
Security Typecommon
Shares to be Sold25,000
Aggregate Market Value$513,567.88
Approx. Price Per Share$20.54
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Contextual Analysis

Prior 3-Month Sale History

The most critical context for this filing is the extensive history of sales by the same insider in the preceding three months, as detailed in the Form 144. This demonstrates a clear pattern of divestment.

Sale DateShares SoldGross Proceeds
08/21/2025100,000$2,299,011
08/26/202525,000$572,717
08/27/202511,865$271,756
09/02/202525,000$562,150
09/03/202525,000$560,251
09/04/202525,000$562,756
09/05/202525,000$563,682
09/08/20252,014$45,207
09/11/2025100,000$2,200,741
09/12/202528,700$628,929
09/16/202525,000$541,518
09/17/202585,785$1,873,875
09/18/2025150,000$3,294,425
09/19/202510,613$234,547
09/22/202550,000$1,092,666
09/23/202525,000$550,386
09/26/20255,627$123,794
09/29/202518,134$399,822
10/08/202525,000$513,186
10/09/20253,145$65,270
Total765,882$16,956,689

Investment Insights

  • High-Volume Divestment: The insider has liquidated nearly $17 million in stock over three months, with this filing proposing an additional $0.5M sale. This is a substantial divestment of their holdings.
  • Former Director Status: The selling party is a 'former director'. This often means the sales are part of a planned liquidation following their departure from the company and may not be related to the company's current performance or future outlook.
  • No 10b5-1 Plan Mentioned: The filing does not mention a pre-arranged 10b5-1 trading plan, which means these sales may be discretionary. However, for former insiders, such plans are less common.

Risk Assessment

Risk Level: Medium

Risk Factors

  • Negative Signal: A consistent, high-volume sell-off by an insider, even a former one, can be perceived negatively by the market and may signal a lack of confidence in the long-term prospects of the company.
  • Supply Overhang: The continuous sale of large blocks of shares can create an oversupply in the market, potentially capping or depressing the stock price in the short to medium term.

Market Considerations

  • Motivation is Key: The reason for the sale is unknown. It could be for personal financial planning, diversification, or other reasons unrelated to the company's fundamentals. However, the market often defaults to a cautious interpretation.
  • Investor Sentiment: Traders and algorithms may flag this pattern of selling, leading to increased short interest or a reduction in bullish positions until the selling pressure subsides.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#SGRY#SurgeryPartners#Form144#InsiderSell#StockSale#HighSignificance#Investing#StockMarket#HealthcareStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.